Efficacy and Toxicity of Therapy for Patients with Intermediate-Risk Hodgkin's Lymphoma: Results of Multicenter Randomized Study
Journal: CyberLeninK (CyberLeninka)
Year: 2015

ABSTRACT Objective. To study the efficacy and toxicity of various treat-ment schemes for patients with intermediate-risk Hodgkin’s lymphoma (HL). Methods. This article presents an analysis of the immedi-ate results of complex treatment of 103 intermediate-risk HL patients (stage IIA and IIB with one or more unfavor-able prognostic factors), who have been treated at the Na-tional Cancer Institute (Kyiv) and the Crimean Oncology Dispensary (Simferopol) from 2009 to 2014 (study group). Patients wer